Vivo Ventures VII Affiliates Fund, L.P.
CIK 0001538309 Name as filed on the most recent filing
Filed as Vivo Ventures VII Affiliates Fund, L.P. (16)
39 transaction lines · from 16 filings · filed 2013-05-20 to 2022-01-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Sierra Oncology, Inc. 2 filings
- ISSUER Airxpanders Inc 1 filings
- ISSUER Codexis Inc 4 filings
- ISSUER Aclaris Therapeutics, Inc. 4 filings
- ISSUER MEI Pharma, Inc. 5 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2022-01-31 |
Sierra Oncology, Inc. SRRA |
P, Open-market purchase | 800,000 acquired | 27.00 | 21,600,000.00 | Form 4, filing 0001213900-22-004647 | |
| 2018-08-30 |
Airxpanders Inc AXP |
P, Open-market purchase | 19,712,492 acquired | 0.17 | 3,295,928.66 | Form 4, filing 0001615774-18-009063 | |
| 2018-08-30 |
Airxpanders Inc AXP |
P, Open-market purchase | 429,631 acquired | 0.17 | 71,834.30 | Form 4, filing 0001615774-18-009063 | |
| 2017-09-14 |
Codexis Inc CDXS |
S, Open-market sale | 1,037,390 disposed | 5.78 | 5,990,927.25 | Form 4, filing 0001615774-17-005168 | |
| 2017-09-14 |
Codexis Inc CDXS |
S, Open-market sale | 22,610 disposed | 5.78 | 130,572.75 | Form 4, filing 0001615774-17-005168 | |
| 2017-03-02 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 122,334 disposed | 31.20 | 3,816,820.80 | Form 4, filing 0001615774-17-000876 | |
| 2017-03-02 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 2,666 disposed | 31.20 | 83,179.20 | Form 4, filing 0001615774-17-000876 | |
| 2017-03-01 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 97,867 disposed | 30.98 | 3,031,919.66 | Form 4, filing 0001615774-17-000876 | |
| 2017-03-01 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 2,133 disposed | 30.98 | 66,080.34 | Form 4, filing 0001615774-17-000876 | |
| 2017-02-28 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 195,734 disposed | 30.50 | 5,969,887.00 | Form 4, filing 0001615774-17-000876 | |
| 2017-02-28 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 4,266 disposed | 30.50 | 130,113.00 | Form 4, filing 0001615774-17-000876 | |
| 2016-11-18 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 440,402 disposed | 22.72 | 10,005,933.44 | Form 4, filing 0001615774-16-008485 | |
| 2016-11-18 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 9,598 disposed | 22.72 | 218,066.56 | Form 4, filing 0001615774-16-008485 | |
| 2016-11-16 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 448,063 disposed | 23.25 | 10,417,464.75 | Form 4, filing 0001615774-16-008485 | |
| 2016-11-16 |
Aclaris Therapeutics, Inc. ACRS |
S, Open-market sale | 9,765 disposed | 27.30 | 266,584.50 | Form 4, filing 0001615774-16-008485 | |
| 2016-09-08 |
Codexis Inc CDXS |
S, Open-market sale | 109,219 disposed | 4.25 | 464,497.49 | Form 4, filing 0001225208-16-039231 | |
| 2016-09-08 |
Codexis Inc CDXS |
S, Open-market sale | 2,381 disposed | 4.25 | 10,126.15 | Form 4, filing 0001225208-16-039231 | |
| 2016-08-16 |
Codexis Inc CDXS |
S, Open-market sale | 36,107 disposed | 4.21 | 151,909.37 | Form 4, filing 0001225208-16-038071 | |
| 2016-08-16 |
Codexis Inc CDXS |
S, Open-market sale | 787 disposed | 4.21 | 3,311.07 | Form 4, filing 0001225208-16-038071 | |
| 2016-08-15 |
Codexis Inc CDXS |
S, Open-market sale | 48,934 disposed | 4.27 | 209,143.92 | Form 4, filing 0001225208-16-038071 | |
| 2016-08-15 |
Codexis Inc CDXS |
S, Open-market sale | 1,066 disposed | 4.27 | 4,556.08 | Form 4, filing 0001225208-16-038071 | |
| 2016-08-04 |
Codexis Inc CDXS |
S, Open-market sale | 48,934 disposed | 4.17 | 203,976.49 | Form 4, filing 0001225208-16-037558 | |
| 2016-08-04 |
Codexis Inc CDXS |
S, Open-market sale | 1,066 disposed | 4.17 | 4,443.51 | Form 4, filing 0001225208-16-037558 | |
| 2016-08-03 |
Codexis Inc CDXS |
S, Open-market sale | 29,360 disposed | 4.30 | 126,198.09 | Form 4, filing 0001225208-16-037558 | |
| 2016-08-03 |
Codexis Inc CDXS |
S, Open-market sale | 640 disposed | 4.30 | 2,750.91 | Form 4, filing 0001225208-16-037558 | |
| 2015-10-13 |
Aclaris Therapeutics, Inc. ACRS |
P, Open-market purchase | 444,850 acquired | 11.00 | 4,893,350.00 | Form 4, filing 0001209191-15-075198 | |
| 2015-10-13 |
Aclaris Therapeutics, Inc. ACRS |
P, Open-market purchase | 9,695 acquired | 11.00 | 106,645.00 | Form 4, filing 0001209191-15-075198 | |
| 2015-10-07 |
Aclaris Therapeutics, Inc. ACRS |
P, Open-market purchase | 13,067 acquired | 11.00 | 143,737.00 | Form 4, filing 0001209191-15-075023 | |
| 2015-10-07 |
Aclaris Therapeutics, Inc. ACRS |
P, Open-market purchase | 285 acquired | 11.00 | 3,135.00 | Form 4, filing 0001209191-15-075023 | |
| 2015-07-21 |
ProNAi Therapeutics Inc DNAI |
P, Open-market purchase | 215,307 acquired | 17.00 | 3,660,219.00 | Form 4, filing 0001209191-15-061940 | |
| 2015-07-21 |
ProNAi Therapeutics Inc DNAI |
P, Open-market purchase | 4,693 acquired | 17.00 | 79,781.00 | Form 4, filing 0001209191-15-061940 | |
| 2013-10-29 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 756 disposed | 8.27 | 6,252.12 | Form 4, filing 0000904454-13-001121 | |
| 2013-10-28 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 38,953 disposed | 8.30 | 323,434.55 | Form 4, filing 0000904454-13-001121 | |
| 2013-10-25 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 259,900 disposed | 8.20 | 2,131,180.00 | Form 4, filing 0000904454-13-001121 | |
| 2013-10-02 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 486,107 disposed | 10.00 | 4,861,507.50 | Form 4, filing 0000904454-13-001090 | |
| 2013-10-01 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 95,539 disposed | 11.00 | 1,050,671.04 | Form 4, filing 0000904454-13-001090 | |
| 2013-06-28 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 7,337 disposed | 7.58 | 55,597.58 | Form 4, filing 0000904454-13-000776 | |
| 2013-06-11 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 236,273 disposed | 7.80 | 1,842,929.40 | Form 4, filing 0000904454-13-000695 | |
| 2013-05-16 |
MEI Pharma, Inc. MEIP |
S, Open-market sale | 17,428 disposed | 9.07 | 157,993.53 | Form 4, filing 0000904454-13-000586 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Vivo Ventures VII Affiliates Fund, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001538309
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6